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Ethnopharmacological relevance: Lecythis pisonis Camb., also known in Brazil as sapucaia, is used in folk
medicine against pruritus, muscle pain and gastric ulcer.
Aim of the study: To investigate the antinociceptive effect of ethanol extract from Lecythis pisonis leaves
(LPEE), fractions (hexane-LPHF, ether-LPEF and ethyl acetate-LPEAF) and mixture of triterpenes [ursolic
and oleanolic acids (MT)] in mice.
Materials and methods: LPEE and LPEF were evaluated on the acetic acid induced writhings and
formalin, capsaicin and glutamate tests. In addition, MT was investigated on the writhings induced by
acetic acid, capsaicin and glutamate tests. In the study of some possible mechanisms involved on the
antinociceptive effect of LPEF, it was investigated the participation of opioid system, KþATP channels and
L-arginine-nitric oxide pathway.
Results: LPEE (12.5 and 25 mg/kg, p.o.), LPEF and MT (6.25, 12.5 and 25 mg/kg, p.o.) reduced the
writhings in comparison to saline. LPEE (100 mg/kg, p.o.) and LPEF (50 mg/kg, p.o.) were effective in
inhibiting both phases of formalin test. In capsaicin test, LPEE (100 and 200 mg/kg, p.o.), LPEF (12.5–
50 mg/kg, p.o) and MT (6.25–25 mg/kg, p.o.) showed a signiﬁcant antinociceptive effect compared to
the control. LPEE (25 and 50 mg/kg, p.o.), LPEF (50 and 100 mg/kg, p.o.) and MT (12.5 and 25 mg/kg,
p.o.) reduced the glutamate-evoked nociceptive response. Treatment with naloxone, L-arginine and
glibenclamide reversed the effect of LPEF in glutamate test.
Conclusions: These results indicate the antinociceptive effect of Lecythis pisonis leaves and suggest that
this effect may be related to opioid pathway, KþATP channels, and L-arginine-nitric oxide modulation.
Furthermore, these data support the ethnomedical use of this plant.
& 2013 Elsevier Ireland Ltd. Open access under the Elsevier OA license. 1. Introduction
Lecythis pisonis Camb. belongs to the Lecythidaceae botanic
family and is popularly known in Brazil as ‘‘sapucaia’’ or
‘‘cumbuca de macaco’’. It is found mainly in the states of Piauı´,
from Pernambuco to S~ao Paulo and in the Amazon region. The
seeds of this species are a valuable source of essential amino
acids, fatty acids and minerals, being a functional and nutritious
food for human consumption (Vallilo et al., 1999). In traditional
medicine, it is used for the treatment of itching (pruritus) in the
body (Franco and Barros, 2006) and as an emollient, reducing
muscle pain (Agra et al., 2007).rleukin-8; LD50, lethal dosis
NMDA, N-methyl-D-aspar-
tumor necrosis factor-alfa;
ubfamily V member 1
ax: þ55 86 3237 18 50.
a).
r the Elsevier OA license. Phytochemical investigation of the ethanolic extract of
Lecythis pisonis leaves has led to the identiﬁcation of different
fractions such as hexane, ether and ethyl acetate. However, the
chromatographic fractioning of the ethereal fraction and its
subfractions spectrometric analysis resulted in the identiﬁcation
of 10 isoprenic origin substances, distributed in three binary
mixtures of triterpenoid skeletons and ursano oleanano, a mix-
ture of steroid and triterpenoid skeleton called friedelan-3-ol. The
presence of triterpenes in the species was conﬁrmed by the
isolation and identiﬁcation of the mixture of ursolic and oleanolic
acids (Oliveira et al., 2012).
Plants rich in triterpenoids are widely used in medicine because
of its anti-inﬂammatory, protecting of the vascular system, anti-
allergic, analgesic and antipyretic properties (Andrade et al., 2007).
Several species have triterpenoids in its composition and show
antinociceptive activity, for example Achyranthes aspera Linn. (Barua
et al., 2010), Muehlenbeckia platyclada F. Muell. (Fagundes et al.,
2010) and Aegiceras corniculatum L. Blanco (Roome et al., 2011). The
species Emilia sonchifolia L. has demonstrated antinociceptive
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Fig. 1. Structure of ursolic (1) and oleanolic (2) acids.
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ing the presence of ursolic acid, sitosterol and stigmasterol (Couto
et al., 2011).
There are reports showing that ursolic acid is able to produce a
signiﬁcant reduction in acetic acid-induced writhings, indicating
that it is effective against inﬂammatory pain (Taviano et al.,
2007). In addition, the oleanolic acid inhibits visceral nociception
in the mustard oil-induced colonic nociception in mice through
an opioid mechanism, and it may have a modulatory inﬂuence on
vanilloid receptors (Maia et al., 2006).
A previous study provided experimental evidence that justiﬁes
the popular use of Lecythis pisonis leaves in the treatment of
pruritus and suggests that this effect may be related to a
stabilizing action on mast cell membrane (Silva et al., 2012).
The precise relationship between itch and pain remains contro-
versial. Itch seems to share numerous features with pain, including
induction by noxious chemical stimuli, arousal of attention, nega-
tive affective valence and initiation of motor responses (Drzezga
et al., 2001).
By virtue of aforementioned properties, it is expected that
Lecythis pisonis have antinociceptive activity associated with its
antipruriginous effect. So, this study aims to evaluate Lecythis
pisonis Camb. antinociceptive effect in animal models of chemi-
cally induced acute pain and some of the possible mechanisms
involved in this effect.2. Materials and methods
2.1. Plant material and identiﬁcation
Leaves of Lecythis pisonis Camb. (Lecythidaceae) were collected
in July 2008 at the Centre for Agrarian Sciences, Federal
University of Piauı´ (CCA-UFPI) in the city of Teresina, Piauı´ state,
Brazil (51 020 53.200S, 421 470 16.800O to 68 m sea level). After
collection, a voucher specimen has been identiﬁed by Gardene M.
Sousa and deposited in the Graziela Barroso Herbarium of Federal
University of Piauı´ (TEPB 26488).
2.2. Extraction and isolation
Dried and powdered leaves of Lecythis pisonis (2 kg) were
extracted at room temperature, consecutively six times with
ethanol 98%. The solvent was removed by evaporation under
reduced pressure using Hedolph Rotary Evaporator to yield the
ethanol extract (LPEE, 272.0 g, 13.6%). Part of the LPEE (200.0 g)
was fractionated by serial extraction with hexane, ethyl ether,
EtOAc and H2O to yield hexane (LPHF, 60.0 g, 34.0%), ethyl ether
(LPEF, 24.0 g, 12.0%), EtOAc (LPEAF, 21.0 g, 10.5%) and H2O (LPAF,
70.0 g, 37.5%) fractions and a precipitate formed in the EtOAc
phase which was separated by simple ﬁltration (ppt-EtOAc,
10 g, 5%). The ethereal fraction (LPEF, 10 g) was fractionated on a
silica gel column with elution gradient from CHCl3 toMeOH to yield
103 fractions collected as follows: 1–31 (CHCl3, 100%), 32–54
(CHCl3-MeOH, 98:2), 55–62 (CHCl3-MeOH, 95:5), 63–72 (CHCl3-
MeOH, 9:1), 73–89 (CHCl3-MeOH, 8:2), 90–96 (CHCl3-MeOH, 7:3),
97–103 (MeOH 100%). The fraction B (17–23, 603 mg) was
suspended in MeOH to form an amorphous precipitate (F17-ppt,
475 mg, 4.75%) composed of a mixture of ursolic and oleanolic
acid triterpenes (Fig. 1). The structural characterization of this
mixture was performed using spectroscopic methods such as
nuclear magnetic resonance (1H and 13C NMR) and compared
with literature data (Mahato and Kundu, 1994; Junges et al.,
2000). The ratio of ursolic acid and oleanolic acid in this mixture
was 59:41, calculated by 1H NMR, by dividing the signal area of
oleﬁnic hydrogens d¼5.15 (ursolic acid) and d¼5.19 (oleanolicacid) with the signal area of d¼3.11 (dd, J¼7.0 and 9.0 Hz)
attributed to H-3 in the two triterpenes and multiplying by 100
(Oliveira et al., 2012). The 1H and 13C NMR spectra were recorded
on a Varian Inova 500 spectrometer, in CDCl3, at 500 and
125 MHz, respectively, using TMS as internal standard. The
chemical shifts values are on d scale and the coupling constants
(J) values are in Hertz. Column chromatography was carried out
using silica gel 60 (0.063–0.200 mm). Thin layer chromatography
(TLC) was carried out on silica gel 60 G (Merck) plates (0.25 mm
layer thickness). Extract, fractions and mixture of triterpenes of
Lecythis pisonis leaves were dissolved in or diluted with physio-
logical saline (0.9%) and prepared immediately before each
experiment. The triterpenes concentration of the extract, fractions
and mixture were adjusted to a volume of 10 mL/kg.
2.3. Chemicals and reagents
Capsaicin, glibenclamide, glutamate, L-arginine, L-NOARG,
Dizocilpine (MK 801), naloxone and Tween 80 were obtained
from Sigma Chemical Co. (St. Louis, MO, USA). Morphine was
purchased from Crista´lia Produtos Quı´micos e Farmaceˆuticos Ltda.
(SP, Brazil). Formaldehyde was obtained from Dinaˆmica Quı´mica
Contemporaˆnea Ltda. (SP, Brazil). Acetic acid and sodium chloride
were from Vetec Quı´mica Fina Ltda. (RJ, Brazil).
2.4. Animals
Male Swiss mice 20–30 g (n¼6–11) were used, 10 weeks old
from the Sector Animal House for Research on Medicinal Plants of
the Federal University of Piauı´. The animals were kept at 2471 1C
with a light/dark cycle of 12 h, with free access to food and water.
They were fasted for a period of 18 h and were accustomed to the
test environment for 1 h before each experiment. All experimen-
tal protocols were approved by the Ethics Committee for Animal
Experimentation at the Federal University of Piauı´ (No. 52/2010).
2.5. Antinociceptive tests
2.5.1. Acetic acid-induced writhing
The procedure was similar to a previously described method
(Collier et al., 1968). Swiss mice (n¼6–8) were pretreated with
saline vehicle (0.1 mL/10 g), LPEE, LPEF and MT (6.25, 12.5 and
25 mg/kg, p.o.) 60 min before the intraperitoneal administration
of 0.75% acetic acid, and then, the total number of writhings was
counted over a period of 20 min. The strength of the elicited
antinociceptive effect was compared with that of an effective dose
M.S. Brand ~ao et al. / Journal of Ethnopharmacology 146 (2013) 180–186182of morphine (2.5 mg/kg, s.c.) administered 30 min before the
acetic acid injection.
2.5.2. Formalin test
Mice (n¼6–8) were given orally LPEE (25, 50, 100 and 200 mg/
kg), LPEF (25, 50 and 100 mg/kg) or vehicle (10 mL/kg) 1 h before
the test. Morphine (5 mg/kg) was administered subcutaneously
30 min before the test and used as positive control. The right hind
foot pad was injected with formalin (20 mL, 2%) in the intraplantar
region. Nociception was evaluated by quantifying paw licking
time during the ﬁrst 5 min (ﬁrst phase) and at 15–30 min (second
phase) (Hunskaar and Hole, 1987).
2.5.3. Capsaicin test
The animals were individually placed in the observation
chamber for an adjustment period of 20 min. After this period,
mice (n¼6–8) were given orally LPEE (50, 100 and 200 mg/kg),
LPEF (12.5, 25 and 50 mg/kg), MT (6.25, 12.5 and 25 mg/kg) or
vehicle (10 mL/kg). Morphine (5 mg/kg) was administered sub-
cutaneously 30 min before the test and used as a positive control.
One hour after these treatments, the right hind paw was injected
with capsaicin (2 mg/paw) prepared in 5% Tween solution and 2%
ethanol. Nociception was evaluated immediately after injection
and quantiﬁed by paw licking time during a 5 min period
(Sakurada et al., 1992).Table 1
Antinociceptive effect of the ethanol extract, ethereal fraction and the mixture of
ursolic and oleanolic acids from leaves of Lecythis pisonis on acetic acid-induced
writhings in mice.
Treatment Dose (mg/kg) Number or writhings Inhibition (%)
Vehicle – 73.2572.37 –
Morphine 2.50 6.1770.91 91.58
LPEE 6.25 60.4374.80 17.50
12.50 31.1772.31nnn 57.45
25.00 42.1776.01nnn 42.43
LPEF 6.25 48.7177.63nnn 33.49
12.50 34.0073.39nnn 53.58
MT 25.00 38.6771.91nnn 47.21
6.25 58.2975.55n 20.43
12.50 42.0074.57nnn 42.66
25.00 39.5772.83nnn 49.98
Mice were treated with extract (LPEE), fraction (LPEF) or mixture of triterpenic
acids (MT) 60 min (p.o.) before writhing test. Data represent the mean7S.E.M. of
6–8 animals. The symbols report signiﬁcance level. npo0.05, nnnpo0.001.
Table 2
Antinociceptive effect of the ethanol extract and ethereal fraction of leaves from Lecyt
Treatment Dosage
(mg/
kg)
Licking time (s)
0–5 min
Vehicle 1 – 78.6978.27
LPEE 25 72.8673.05
50 74.9276.95
100 45.8273.08nnn
200 46.0974.19nnn
Morphine 1 5 8.8871.79nnn
Vehicle 2 – 82.7878.50
LPEF 25 57.2279.27
50 53.7074.26n
100 52.0374.58n
Morphine 2 5 8.0671.65nnn
Mice were treated with extract (LPEE) or fraction (LPEF) 60 min (p.o.) before formalin
vehicle 1 and morphine 1, while LPEF to vehicle 2 and morphine 2. The symbols repor2.5.4. Glutamate test
The procedure used was similar to the previously described by
Beirith et al. (2002). Mice (6–11) received an intraplantar injec-
tion of glutamate (20 mmol/paw) 60 min after oral administration
of LPEE (12.5, 25 and 50 mg/kg), LPEF (25, 50 and 100 mg/kg), MT
(6.25, 12.5 and 25 mg/kg) or vehicle (0.1 mL/10 g), and 30 min
after the administration of MK 801 (0.03 mg/kg, i.p.) as a positive
control. Animals were observed individually for 15 min following
glutamate injection. The amount of time spent licking the injected
paw was taken to indicate nociception.
2.6. Evaluation of possible mechanisms of action of the LPEF in mice
To address some of the mechanisms by which LPEF of Lecythis
pisonis causes antinociception in the glutamate-induced nocicep-
tion, animals (6–11) were treated with different drugs. The doses
of the drugs used were selected on the basis of the literature
(Santos et al., 2005) data and also based on previous results from
our laboratory.
2.6.1. Participation of opioid system
Mice (6–11) were pretreated with naloxone (2 mg/kg, i.p., a
non-selective opioid receptor antagonist), and after 20 min the
animals received an injection of LPEF (50 mg/kg, p.o.), morphine
(5 mg/kg, s.c.) or vehicle (10 ml/kg, p.o.). One hour after admin-
istration of LPEF or 30 min after administration of morphine, it
was injected 20 mL of glutamate solution (20 mmol/paw, i.pl.) and
evaluated the nociceptive response like in glutamate test.
2.6.2. Participation of Kþ ATP channels
Mice (n¼6–11) were previously treated with glibenclamide
(3 mg/kg, i.p.) and 20 min latter, they received LPEF (50 mg/kg,
p.o.) or vehicle (0.1 mL/10 g, p.o.). After 60 min, the animals were
assessed for nociception induced by intraplantar injection of
20 mL solution of glutamate (20 mmol/paw).
2.6.3. Participation of L-arginine-nitric oxide
Mice (7–11) were pre-treated with L-arginine (600 mg/kg, i.p.,
a nitric oxide precursor) and after 20 min, they received LPEF
(50 mg/kg, p.o.), N$-nitro-L-arginine (L-NOARG, 75 mg/kg, i.p., a
nitric oxide inhibitor) or vehicle (10 ml/kg, p.o.). The nociceptive
responses to glutamate were recorded 1, 0.5 and 1 h after the
administration of LPEF, L-NOARG, or vehicle, respectively.his pisonis in the formalin induced nociceptive response in mice.
Inhibition
(%)
15–30 min Inhibition
(%)
– 115.6277.38 –
7.41 96.6971.83 16.37
4.79 74.1476.89nnn 35.88
41.77 81.0879.36nn 29.87
41.43 104.49710.62 9.63
88.94 8.7072.67nnn 92.47
– 124.6076.07 –
30.88 102.00712.45 18.14
35.13 49.3776.85nnn 60.37
37.15 82.42711.56n 33.86
93.64 5.2671.95nnn 95.78
test. Data represent the mean7S.E.M. of 6–8 animals. The LPEE was compared to
t signiﬁcance level. npo0.05, nnpo0.01, nnnpo0.001.
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The results were expressed as the mean7S.E.M. and analyzed
by one-way ANOVA followed by post hoc Bonferroni test. Differ-
ences between groups were considered signiﬁcant when po0.05
(GraphPad Prism software version 3.0).C 50 100 200 5
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Fig. 2. Effect of ethanol extract from Lecythis pisonis—LPEE (Panel A), ethereal
fraction—LPEF (Panel B) and the mixture of ursolic and oleanolic acids—MT (Panel
C) administered orally against capsaicin induced nociception in mice. Each column
represents the mean7S.E.M of 6–8 animals. Control value (C) indicates the
animals treated with vehicle and the asterisks denote the signiﬁcance levels,
when compared with control groups (one-way ANOVA followed by Bonferroni
test) (*po0.05, **po0.01, ***po0.001).3. Results
3.1. Acetic acid-induced writhing
LPEE (12.5 and 25 mg/kg, p.o.), LPEF and MT (6.25, 12.5 and
25 mg/kg, p.o.) reduced the number of writhings when compared
to vehicle. The positive control (morphine 2.5 mg/kg s.c.) was
effective when compared to vehicle (Table 1).
3.2. Formalin test
LPEE (100 mg/kg p.o.) signiﬁcantly reduced the time (seconds)
the animal stayed licking its stimulated paw in both phases of
testing when compared with vehicle, while LPEE (50 mg/kg p.o.)
was effective only in the second phase and LPEE (200 mg/kg p.o.)
showed signiﬁcant result only in the ﬁrst phase. LPEF (50 and
100 mg/kg p.o.) was effective in two phases of response compared
with vehicle. Morphine was used as positive control (5 mg/kg s.c.)
and decreased signiﬁcantly response time of the animals when
compared to vehicle in both phases (Table 2).
3.3. Capsaicin test
The results depicted in Fig. 2A show that LPEE (100 and
200 mg/kg p.o.) reduced the time (seconds) of paw licking of
the animal (37.2374.45 and 24.3472.36) after administration of
capsaicin in relation to vehicle (62.8178.32), presenting an
inhibition of 40.73% and 61.24%, respectively. The results pre-
sented in Fig. 2B show that LPEF orally produced marked inhibi-
tion of the capsaicin-induced neurogenic pain in mice in all doses
tested (12.5, 25 and 50 mg/kg) (32.4274.00, 25.4774.11,
35.4174.31) compared to vehicle (62.8178.32), corresponding
to inhibition of 48.38%, 59.45% and 43.62%, respectively. MT was
effective at the doses of 6.25, 12.5 and 25 mg/kg (30.4075.33,
27.3772.50, 39.3876.64) compared to vehicle (62.8178.32)
(Fig. 2C), with inhibition of 51.60%, 56.43% and 37.30%, respec-
tively. Morphine (5 mg/kg s.c.) caused a reduction in the response
(5.4070.36) when compared to vehicle, presenting an inhibition
of 91.40%.
3.4. Glutamate test
Fig. 3A shows that LPEE (25 and 50 mg/kg p.o.) presented a
signiﬁcant reduction of glutamate-induced nociception (64.247
8.29, 47.7175.00 seconds) relative to vehicle (92.5472.06), with
corresponds inhibition of 30.58% and 48.43%, respectively; the
positive control (MK801 0.03 mg/kg i.p.) signiﬁcantly reduced the
time the animal stayed licking its stimulated paw (20.4573.28)
when compared to vehicle, presenting an inhibition of 77.90%.
Fig. 3B shows that LPEF (50 and 100 mg/kg p.o.) produced
attenuation of the glutamate-induced nociception (53.8475.41,
67.37710.45) compared to the vehicle (100.8676.46), leading to
an inhibition of 46.62% and 33.20%, respectively; MK801
(0.03 mg/kg i.p.) showed a decrease of the response (20.457
3.28) when compared to vehicle, corresponding to inhibition of
79.72%. MT decreased signiﬁcantly and dose-dependent response
time of the animal at doses of 12.5 and 25 mg/kg p.o.
(88.9677.86, 40.5075.65) compared to vehicle (121.3375.38),corresponding to losses of 26.68% and 66.62%, respectively
(Fig. 3C); MK801 (0.03 mg/kg i.p.) produced marked inhibition
of the nociception (20.4573.28) when compared to vehicle,
corresponding to decreasing of 83.14%.
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Fig. 3. Effect of ethanolic extract from Lecythis pisonis—LPEE (Panel A), ethereal
fraction—LPEF (Panel B) and the mixture of ursolic and oleanolic acids—MT
(Panel C) administered orally against glutamate induced nociception in mice.
Each column represents the mean7S.E.M of 6–11 animals. Control value
(C) indicates the animals treated with vehicle; the asterisks denote the signiﬁ-
cance levels, when compared with control groups; and a when compared to MT
12.5 mg/kg group (one-way ANOVA followed by Bonferroni test) (*po0.05,
**po0.01, ***po0.001, apo0.001).
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Fig. 4. Effect of LPEF (50 mg/kg, p.o.) against the action of naloxone (2 mg/kg,
i.p.), glibenclamide (3 mg/kg, i.p.), L-arginine (600 mg/kg, i.p.) and vehicle on
glutamate-induced nociception (20 mL, 20 mmol/paw) in mice. Data repre-
sent mean7S.E.M of 6–11 animals. The symbols indicate the level of signi-
ﬁcance (***po0.001 compared with vehicle (C), apo0.001 compared with
the morphine or L-NOARG groups, bpo0.001 compared with group LPEF; þ ,
treatment present;  , missing treatment) (one-way ANOVA followed by
Bonferroni test).
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Naloxone (2 mg/kg i.p.), glibenclamide (3 mg/kg i.p.) and
L-arginine (600 mg/kg i.p.) signiﬁcantly reversed the effect of
LPEF (50 mg/kg p.o.) (Fig. 4).
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The results of this study validate the use of Lecythis pisonis
leaves in the traditional medicine and show for the ﬁrst time that
the ethanol extract (LPEE) and ethereal fraction (LPEF) have an
antinociceptive activity when administered orally in different
models of chemical nociception in mice. These data also conﬁrm
and extend the literature regarding the antinociceptive action of
ursolic and oleanolic acids (main constituents identiﬁed in LPEF)
(Maia et al., 2006; Oliveira et al., 2012).
Oral administration of LPEE from Lecythis pisonis leaves, up to
the dose of 2 g/kg, showed no signs of acute toxicity within 14
days of observation (Silva et al., 2012). The absence of toxicity
presented by LPEE enabled the establishment of the doses used in
this study.
We started the investigation of the antinociceptive activity of
Lecythis pisonis using acetic acid-induced writhing reaction in
mice. LPEE, LPEF and MT (mixture of triterpenes–ursolic and
oleanolic acids) produced marked suppression of writhing
response at dose levels tested. This response has been described
as a typical model of inﬂammatory pain and has long been used as
a screening tool for the assessment of analgesic or anti-
inﬂammatory properties of new agents (Collier et al., 1968).
Protons depolarize sensory neurones by directly activating a
non-selective cationic channel localized on cutaneous, visceral
and other types of peripheral afferent C ﬁbers (Julius and
Basbaum, 2001). Local irritation also induces the release of
endogenous mediators such as bradykinin, prostaglandins and
cytokines (TNF-a, IL-1b and IL-8), which stimulate the nociceptive
neurons. This method shows good sensitivity but poor speciﬁcity
because the abdominal writhing response may be suppressed by
muscle relaxants and other drugs, leaving scope for the misinter-
pretation of results (Le Bars et al., 2001). This can be avoided by
complementing the test with other models of nociception.
Our results also show that LPEE and LPEF were effective in both
phases of the formalin test. The intraplantar injection of formalin
promotes two phases of pain sensitivity. The ﬁrst phase (neurogenic
pain) occurs through direct chemical stimulation promoted by
formalin on nociceptors, in type C and part of the Ad afferent ﬁbers,
and it is associated with the release of excitatory amino acids, nitric
oxide and substance P, among others. The second phase (inﬂamma-
tory pain) is characterized as inﬂammatory pain, associated with the
release of chemical mediators such as histamine, serotonin, brady-
kinin, prostaglandins and excitatory amino acids (Hunskaar and
Hole, 1987; Correˆa and Calixto, 1993).
In addition, LPEE, LPEF and MT were able to inhibit the
neurogenic nociception caused by capsaicin, an alkaloid extracted
from red pepper Capsicum, which stimulates nociceptive and
thermal nerve endings causing intense pain. Capsaicin acts
speciﬁcally in unmyelinated type C ﬁbers and poorly in myeli-
nated and thin Ad ﬁbers through the vanilloid receptor (TRPV-1)
in the peripheral nervous system, by opening a nonselective
cation channel, allowing the inﬂux of cations, mainly Ca2þ and
Naþ , causing depolarization and initiation of action potentials.
Capsaicin determines the release of neuropeptides, especially
tachykinins (substance P, neurokinin A and neurokinin B), which
operate in the transmission of pain sensation, in the nociceptive
pathway and in inﬂammatory processes (Palazzo et al., 2008).
In this study, we also observed that oral administration of
LPEE, LPEF and MT produced a signiﬁcant inhibition of the
nociceptive response caused by glutamate injection into the
mouse hind paw, at doses that did not produce any statistically
signiﬁcant motor dysfunction (Silva et al., 2012). It is known that
glutamate is the major excitatory neurotransmitter involved
in nociceptive signal transmission. Moreover, the intraplantar
injection of glutamate releases excitatory amino acids, PGE2(Prostaglandina E2), NO (Nitric oxide), kinins, protons, SP (Sub-
stance P) and more glutamate in the dorsal horn. Glutamate
induces a nociceptive response through its action on glutamate
receptors that are present in peripheral, spinal and supraspinal
sites of action and is largely mediated by both NMDA (N-methyl-
D-aspartate) and non-NMDA receptors as well as by the release of
NO or by some NO-related substance (Beirith et al., 2002;
Sakurada et al., 2003).
It is known that drugs with sedative activity can also inhibit
scratching behavior and motor response (Watanable et al., 1999).
However, in a previous study LPEE did not alter the locomotor
activity of animals with the highest doses that presented anti-
nociceptive effect (Silva et al., 2012), suggesting that the sedative
action of LPEE may not be involved in the antinociceptive activity
observed here.
Therefore, the suppression of the capsaicin, formalin and
glutamate induced licking response and acetic acid-induced
abdominal writhing, caused by treatment with LPEE and LPEF,
are complementary indications that the antinociceptive action of
this plant could be associated with its ability to inhibit NO
production or through interaction with the glutamatergic system.
This fact has been corroborated with the reversion of LPEF
antinociceptive effect by the pretreatment with L-arginine (sub-
strate for NO formation) in this model.
In the present study, we attempted to characterize some of the
mechanisms through which LPEF exerts its antinociceptive action
on glutamate-induced nociception in mice. We observed clearly
that naloxone (nonselective antagonist of opioid receptors), at a
dose that produced no signiﬁcant effect on glutamate nociception,
completely reversed the antinociception induced by both mor-
phine and LPEF. The LPEF antinociception was also antagonized
by pretreatment with glibenclamide (a blocker of KþATP channels),
suggesting that opioid system via KþATP channels is likely to be
involved in LPEF antinociception.
These results can be related to the popular use of this species
like antipruriginous (Silva et al., 2012). Some studies show that
itch-sensing neurons (pruriceptors) can respond to pain-inducing
(algogenic) stimuli. The ‘‘spatial contrast’’ theory proposes that
itch is encoded when a minority of nociceptive ﬁbers are
activated in a receptive ﬁeld, and pain is encoded when a large
number of nociceptor ﬁbers are activated. This theory argues that
pain and itch can be coded in the absence of pain-speciﬁc and
itch-speciﬁc labeled lines (Sikand et al., 2009). However, this
theory appears to conﬂict with increasing evidence supporting
the existence of itch-speciﬁc primary and relay sensory neurons
(Sun and Chen, 2007; Sun et al., 2009).
Various pruritic chemicals produce itch and scratching when
injected or applied to the skin and also play a pivotal role in pain
and hyperalgesia (increased sensitivity to pain) in inﬂamed
tissues by exciting or sensitizing C-ﬁber nociceptors. These
compounds include most proinﬂammatory molecules – such as
histamine, serotonin, and prostaglandins – for which there are
corresponding well-characterized G-protein-coupled receptors
(GPCRs). Based on the marked speciﬁcity of interaction between
GPCRs and ligands, each pruritic chemical has been assumed to
transmit itch and pain messages through the activation of the
same cognate GPCR. Thus, it was thought that differentiation
between itch and pain messages was likely depending on the cell
types that are specialized as parts of neural circuits segregated for
mediating itch or pain responses. Alternatively, it has been
suggested that pruritic compounds may produce complex
response patterns in the skin, and the resultant ‘‘codes’’ may be
processed and deciphered in the central nervous system to
generate the sensations of itch or pain (Han and Simon, 2011).
Increasing evidence also points to the fact that many GPCRs
important for itch also regulate PLC/Ca2þ signaling in nociceptive
M.S. Brand ~ao et al. / Journal of Ethnopharmacology 146 (2013) 180–186186processing. Thus, multiple intracellular signal transduction path-
ways required for pruriception are likely to converge, cross talk,
and even compete with nociceptive signaling in various settings
(Jeffry et al., 2011).
In conclusion, the results presented in this study revealed that
the LPEE, LPEF and MT from leaves of Lecythis pisonis exhibited
antinociceptive activity in animal models of acute nociception,
what can be related to its medicinal use. The opioid pathway, KþATP
channels and negative modulation of L-arginine-nitric oxide are
involved in this effect and the presence of triterpenoids like
ursolic and oleanolic acids may contribute to the antinociceptive
response observed. So, the multiplicity of mechanisms demon-
strated by this vegetable preparation is a great opportunity to
develop novel antagonists, ligands, and ion channel–active drugs
that will provide relief of pain and itch.
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